News

1 to 9 of 96291 results

Indian government takes action over dubious fixed-dose combinations

30-09-2014

In a bid to weed out potentially unsafe combinations, the Central Drugs Standards and Control Organization…

GenericsIndiaPricingRegulation

Pfizer and Kyowa Hakko collaborate on immuno-oncology combination study

30-09-2014

US pharma major Pfizer and Japanese drugmaker Kyowa Hakko Kirin have entered into an agreement to explore…

ImmunologicalsKyowa Hakko KirinmogamulizumabOncologyPF-05082566PfizerPharmaceuticalResearch

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

30-09-2014

Avacta Life Sciences, a division of Avacta Group is investing £10 million ($16.2 million) in the launch…

AvactaBiotechnologyResearchUK

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

30-09-2014

Belgian drugmaker UCB has launched an awareness-raising campaign around brain-related illnesses such…

EuropeNeurologicalPharmaceuticalSocial IssuesUCB

NeoGenomics appoints Robert Shovlin as chief operating officer

NeoGenomics appoints Robert Shovlin as chief operating officer

30-09-2014

Cancer-focused genetic testing service provider NeoGenomics has appointed Robert Shovlin as chief operating…

BiotechnologyBoardroomNeoGenomicsOncologyUSA

Intas launches DoceAqualip in India

30-09-2014

Indian drugmaker Intas Pharmaceuticals says it has successfully launched the world’s first DoceAqualip…

DoceAqualipdocetaxelIndiaIntas PharmaceuticalsMarkets & MarketingOncologyPharmaceutical

1 to 9 of 96291 results

Back to top